Tag: Oxford Biomedica Solutions
Oxford Biomedica, Homology Medicines to create AAV manufacturing JV in US
Oxford Biomedica, a UK-based gene and cell therapy company, has agreed to form a joint venture (JV) to undertake an adeno-associated virus (AAV) manufacturing and ... Read More